• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟并不影响原发性进行性多发性硬化症的残疾累积。

Smoking does not influence disability accumulation in primary progressive multiple sclerosis.

机构信息

Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

出版信息

Eur J Neurol. 2017 Apr;24(4):624-630. doi: 10.1111/ene.13262. Epub 2017 Feb 26.

DOI:10.1111/ene.13262
PMID:28239937
Abstract

BACKGROUND AND PURPOSE

The modifiable risk factor cigarette smoking has been associated with an increased risk of developing multiple sclerosis (MS) and with disease activity in relapsing-remitting MS. However, less is known about the effect of smoking on disease progression in progressive MS. Here the association between cigarette smoking and disability accumulation in primary progressive MS (PPMS) is investigated.

METHODS

Kaplan-Meier survival analyses and Cox proportional hazard modelling were used to investigate the influence of cigarette smoking on the risk of reaching Expanded Disability Status Scale (EDSS) 4 and 6 as well as the time from EDSS 4 to 6 in patients with PPMS.

RESULTS

In all, 416 patients with PPMS and available smoking history were identified. Median time to EDSS 4 was 4 years in ever-smokers and 5 years in never-smokers (P = 0.27), and it was 9 years to EDSS 6 in both ever-smokers and never-smokers (P = 0.48). Smokers were not at increased risk of faster progression to EDSS 4, 6 and from EDSS 4 to 6. Age at disease onset was the strongest risk factor for progression to EDSS 4, 6 and from EDSS 4 to 6.

CONCLUSIONS

Our investigation of a large and well-characterized population based PPMS cohort suggests that cigarette smoking does not influence disability accumulation in PPMS. Our findings support the idea that PPMS is driven by different underlying pathomechanisms than relapsing-remitting MS.

摘要

背景与目的

可改变的风险因素吸烟与多发性硬化症(MS)的发病风险增加以及复发缓解型 MS 的疾病活动有关。然而,关于吸烟对进展型 MS 疾病进展的影响知之甚少。在此,研究了吸烟与原发性进展型 MS(PPMS)残疾累积之间的关系。

方法

使用 Kaplan-Meier 生存分析和 Cox 比例风险模型,调查吸烟对 PPMS 患者达到扩展残疾状态量表(EDSS)4 和 6 的风险以及从 EDSS 4 到 6 的时间的影响。

结果

共确定了 416 名具有可用吸烟史的 PPMS 患者。曾吸烟者达到 EDSS 4 的中位时间为 4 年,从不吸烟者为 5 年(P=0.27),达到 EDSS 6 的中位时间均为 9 年(P=0.48)。吸烟者进展为 EDSS 4、6 以及从 EDSS 4 到 6 的速度没有增加的风险。发病年龄是进展为 EDSS 4、6 以及从 EDSS 4 到 6 的最强危险因素。

结论

我们对一个大型、特征良好的基于人群的 PPMS 队列进行的研究表明,吸烟不会影响 PPMS 中的残疾累积。我们的研究结果支持这样一种观点,即 PPMS 是由与复发缓解型 MS 不同的潜在发病机制驱动的。

相似文献

1
Smoking does not influence disability accumulation in primary progressive multiple sclerosis.吸烟并不影响原发性进行性多发性硬化症的残疾累积。
Eur J Neurol. 2017 Apr;24(4):624-630. doi: 10.1111/ene.13262. Epub 2017 Feb 26.
2
The natural history of early versus late disability accumulation in primary progressive MS.原发性进行性多发性硬化症早期与晚期残疾累积的自然史。
J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):615-21. doi: 10.1136/jnnp-2014-307948. Epub 2014 Aug 4.
3
The natural history of primary progressive multiple sclerosis.原发性进行性多发性硬化症的自然病史。
Neurology. 2009 Dec 8;73(23):1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f.
4
Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.酒精、咖啡、鱼类、吸烟与多发性硬化症的疾病进展。
Eur J Neurol. 2012 Apr;19(4):616-24. doi: 10.1111/j.1468-1331.2011.03596.x. Epub 2011 Nov 25.
5
Modelling the natural history of primary progressive multiple sclerosis.原发性进行性多发性硬化的自然史建模。
J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):13-9. doi: 10.1136/jnnp-2014-307791. Epub 2014 May 14.
6
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.原发性进展型多发性硬化症患者的长期残疾轨迹:潜在类别增长分析。
Mult Scler. 2018 Apr;24(5):642-652. doi: 10.1177/1352458517703800. Epub 2017 Apr 6.
7
Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.近几十年来多发性硬化症达到残疾里程碑风险的变化:瑞典一项全国范围内基于人群的队列研究。
JAMA Neurol. 2019 Jun 1;76(6):665-671. doi: 10.1001/jamaneurol.2019.0330.
8
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.原发性进行性多发性硬化症的抗炎疾病修正治疗与残疾进展:队列研究。
Eur J Neurol. 2019 Feb;26(2):363-370. doi: 10.1111/ene.13824. Epub 2018 Nov 2.
9
Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.光照暴露和对阳光的敏感与多发性硬化症的残疾进展有关。
Mult Scler. 2012 Apr;18(4):451-9. doi: 10.1177/1352458511423778. Epub 2011 Sep 27.
10
Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.静脉注射免疫球蛋白治疗原发性和继发性慢性进行性多发性硬化症:一项随机安慰剂对照多中心研究。
Mult Scler. 2007 Nov;13(9):1107-17. doi: 10.1177/1352458507078400. Epub 2007 Jul 10.

引用本文的文献

1
Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review.吸烟对常见神经系统疾病特定疾病结局的影响:一项范围综述。
J Clin Neurosci. 2024 Apr;122:10-18. doi: 10.1016/j.jocn.2024.02.013. Epub 2024 Feb 29.
2
Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset.吸烟、肥胖和 PPMS 恶化:对 INFORMS 原始试验数据集的分析。
J Neurol. 2022 Mar;269(3):1663-1669. doi: 10.1007/s00415-021-10750-z. Epub 2021 Aug 15.